(Q40337244)

19 September 2017

title

Elevation in plasma Abeta42 in geriatric depression: a pilot study (English)

1 reference

19 September 2017

1

0 references

John J. Sidtis

6

object named as

John J Sidtis

1 reference

19 September 2017

Charles F. Reynolds III

8

object named as

Charles F Reynolds

1 reference

19 September 2017

5

Benoit H Mulsant

1 reference

19 September 2017

P Murali Doraiswamy

2

1 reference

19 September 2017

Lisa M Willoughby

3

1 reference

19 September 2017

Amy E Roth

4

1 reference

19 September 2017

Pankaj D Mehta

7

1 reference

19 September 2017

Bruce G Pollock

9

1 reference

19 September 2017

publication date

1 March 2006

1 reference

19 September 2017

published in

Neurochemical Research

1 reference

19 September 2017

volume

31

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

341-349

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-005-9029-z

19 September 2017

exact match

0 references

cites work

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-005-9029-Z

Depressive symptoms, cognitive decline, and risk of AD in older persons.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-005-9029-Z

'Vascular depression' hypothesis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-005-9029-Z

Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex

21 January 2018

1 reference

12 December 2020

Increased plasma amyloid beta protein 1-42 levels in Down syndrome

1 reference

12 December 2020

Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.

1 reference

12 December 2020

History of depression as a risk factor for dementia: an updated review.

1 reference

12 December 2020

Depressive symptoms and cognitive decline in elderly people. Longitudinal study.

1 reference

12 December 2020

Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients

1 reference

12 December 2020

Selective Reductions in Plasma A 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary Report

1 reference

12 December 2020

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

1 reference

12 December 2020

Exaggerated platelet reactivity in major depression

1 reference

12 December 2020

Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet

1 reference

12 December 2020

Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions

1 reference

12 December 2020

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.

1 reference

12 December 2020

Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer

1 reference

12 December 2020

Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

1 reference

12 December 2020

Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults

1 reference

12 December 2020

Amyloid angiopathy-related vascular cognitive impairment.

1 reference

12 December 2020

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration

1 reference

12 December 2020

Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression

1 reference

12 December 2020

1 reference

12 December 2020

Neuropathologic correlates of late-onset major depression.

1 reference

12 December 2020

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

1 reference

12 December 2020

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

12 December 2020

Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets

1 reference

12 December 2020

A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome

1 reference

12 December 2020

Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study

1 reference

12 December 2020

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

1 reference

12 December 2020

Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

1 reference

12 December 2020

The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

1 reference

12 December 2020

Elevated P-selectin on platelets in depression: response to bupropion

1 reference

12 December 2020

Platelet activation in depression and effects of sertraline treatment: An open-label study

1 reference

12 December 2020

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

12 December 2020

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

1 reference

12 December 2020

Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

1 reference

12 December 2020

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

1 reference

12 December 2020

Prefrontal dysfunction and treatment response in geriatric depression

1 reference

12 December 2020

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

12 December 2020

Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study.

1 reference

12 December 2020

Role of executive function in late-life depression

1 reference

12 December 2020

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

12 December 2020

10.1007/S11064-005-9029-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1002220755

0 references

1 reference